Clinical Trials

NCT03279367 | COMPLETED

20 participants

Optimisation of Hearing Aid Fitting

Study Type:

OBSERVATIONAL

Last Updated:

2021-07-30

Start Date:

2017-12-22

Completion:

2018-09-01

Conditions

• Hearing Loss
• Hearing Abnormality

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT03262688 | UNKNOWN | PHASE3

159 participants

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-06-16

Completion:

2024-01-31

Conditions

• Inguinal Hernia
• Postoperative Pain

Interventions

• DRUG

No Results Yet

NCT03239717 | COMPLETED | NA

16 participants

The Metabolic Response to Reduced Branched-chain Amino Acids in Humans

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-11-28

Completion:

2021-07-16

Conditions

• Diabetes
• Obesity
• Insulin Resistance

Interventions

• OTHER

No Results Yet

NCT03234374 | COMPLETED | PHASE1

52 participants

Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-06-02

Completion:

2017-08-15

Conditions

• Hernioplasty

Interventions

• COMBINATION_PRODUCT
• DRUG

Results Available

NCT03158116 | TERMINATED | PHASE4

5 participants

The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-07-01

Completion:

2020-02-20

Conditions

• Tracheostomy Infection

Interventions

• DRUG

Results Available

NCT03096353 | COMPLETED | EARLY_PHASE1

29 participants

Sensory and Opioid Mechanisms of Affective Touch

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-08-01

Completion:

2018-10-31

Conditions

• Pain
• Touch

Interventions

• OTHER
• DRUG

Results Available

NCT02988596 | COMPLETED | NA

251 participants

Role of Rehabilitation in Concussion Management: A Randomized Controlled Trial

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-01-31

Completion:

2019-08-31

Conditions

• Concussion, Brain

Interventions

• OTHER

No Results Yet

NCT02966795 | COMPLETED | PHASE3

84 participants

A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2017-01-25

Completion:

2018-06-06

Conditions

• Hepatitis C Virus (HCV)

Interventions

• DRUG

Results Available

NCT02922179 | COMPLETED

103951 participants

Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics

Study Type:

OBSERVATIONAL

Last Updated:

2021-07-30

Start Date:

2011-01-01

Completion:

2015-09-30

Conditions

• Diabetes

Interventions

• DRUG

No Results Yet

NCT02913157 | COMPLETED | PHASE2

35 participants

Hydroxychloroquine in Primary Progressive Multiple Sclerosis

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2016-11-30

Completion:

2021-06-30

Conditions

• Multiple Sclerosis, Primary Progressive

Interventions

• DRUG

No Results Yet

NCT02868229 | COMPLETED | PHASE1/PHASE2

61 participants

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2016-09-12

Completion:

2018-12-11

Conditions

• Anemia

Interventions

• DRUG
• OTHER

Results Available

NCT02694523 | COMPLETED | PHASE3

684 participants

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2016-03-31

Completion:

2017-08-31

Conditions

• Psoriasis

Interventions

• DRUG
• BIOLOGICAL

Results Available

NCT02684370 | COMPLETED | PHASE3

560 participants

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2016-02-29

Completion:

2016-12-31

Conditions

• Psoriasis

Interventions

• DRUG

Results Available

NCT02674568 | COMPLETED | PHASE2

342 participants

Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2016-01-25

Completion:

2018-10-19

Conditions

• Small Cell Lung Cancer

Interventions

• DRUG

Results Available

NCT02640157 | COMPLETED | PHASE3

506 participants

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2015-12-31

Completion:

2016-10-31

Conditions

• Chronic Hepatitis C
• Hepatitis C Virus
• Genotype 3 Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT02584972 | COMPLETED

40 participants

Postural Control During Walking and Standing Among Children With Autism Spectrum Disorder

Study Type:

OBSERVATIONAL

Last Updated:

2021-07-30

Start Date:

2015-11-30

Completion:

2017-10-31

Conditions

• Autism Spectrum Disorder

Interventions

• OTHER

No Results Yet

NCT02582632 | COMPLETED | PHASE3

166 participants

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2015-11-24

Completion:

2016-08-24

Conditions

• Hepatitis C Infection
• Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT02247401 | COMPLETED | PHASE3

160 participants

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-11-04

Completion:

2016-08-01

Conditions

• HCV
• Hepatitis C Infection
• Genotype 4

Interventions

• DRUG

Results Available

NCT02243293 | COMPLETED | PHASE2/PHASE3

694 participants

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-09-19

Completion:

2016-10-25

Conditions

• Chronic Hepatitis C
• Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT02076152 | COMPLETED | NA

11 participants

FMISO PET Study of Glioblastoma

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-02-28

Completion:

2019-04-30

Conditions

• Recurrent Glioblastoma

Interventions

• DEVICE
• DRUG

Results Available

NCT02066389 | COMPLETED | PHASE2

300 participants

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-03-26

Completion:

2015-07-02

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG

Results Available

NCT02023112 | COMPLETED | PHASE3

171 participants

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-01-31

Completion:

2015-04-30

Conditions

• Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT01946152 | TERMINATED | PHASE1/PHASE2

21 participants

Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2014-03-05

Completion:

2020-03-18

Conditions

• Multiple Myeloma-Light Chain Only
• Recurrent Plasma Cell Myeloma
• Refractory Plasma Cell Myeloma

Interventions

• DRUG
• BIOLOGICAL
• OTHER

Results Available

NCT01737866 | COMPLETED | PHASE1

13 participants

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-11-30

Completion:

2013-01-31

Conditions

• Heart Failure

Interventions

• DRUG

No Results Yet

NCT01685203 | COMPLETED | PHASE2

316 participants

A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-08-31

Completion:

2014-06-30

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG

Results Available

NCT01651936 | TERMINATED | PHASE2

56 participants

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-08-29

Completion:

2013-10-08

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG

Results Available

NCT01547780 | COMPLETED | PHASE1/PHASE2

52 participants

Translocator Protein and Inflammation After Traumatic Brain Injury

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-01-20

Completion:

2017-09-28

Conditions

• Traumatic Brain Injury (TBI)
• Healthy

Interventions

• DRUG

Results Available

NCT01506947 | COMPLETED | PHASE4

65 participants

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-05-10

Completion:

2016-04-07

Conditions

• Moderate to Severe Secondary Hyperparathyroidism
• Stage 5 Chronic Kidney Diseases

Interventions

• DRUG

Results Available

NCT01505868 | COMPLETED | PHASE1/PHASE2

170 participants

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2012-07-11

Completion:

2019-12-09

Conditions

• Castration Levels of Testosterone
• Castration-Resistant Prostate Carcinoma
• Lymphadenopathy
• Metastatic Prostate Carcinoma
• Prostate Adenocarcinoma
• Prostate Carcinoma Metastatic in the Bone
• Prostate Small Cell Carcinoma

Interventions

• DRUG
• OTHER

Results Available

NCT01352585 | COMPLETED

47 participants

Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

Study Type:

OBSERVATIONAL

Last Updated:

2021-07-30

Start Date:

2011-07-19

Completion:

2013-09-19

Conditions

• Essential Thrombocythemia (ET)

Interventions

• DRUG

Results Available

NCT01077167 | WITHDRAWN | PHASE2

0 participants

Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2010-07-31

Completion:

2011-05-31

Conditions

• Heart Failure

Interventions

• DRUG

No Results Yet

NCT00931762 | TERMINATED | PHASE2

35 participants

A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2009-08-31

Completion:

2011-08-29

Conditions

• Primary Myelofibrosis
• Post-Polycythemia Vera
• Post-Essential Thrombocytopenia

Interventions

• DRUG

Results Available

NCT00805792 | COMPLETED | PHASE2

33 participants

Mayo Acute Stroke Trial for Enhancing Recovery

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2008-11-30

Completion:

2010-09-30

Conditions

• Ischemic Stroke

Interventions

• DRUG

Results Available

NCT00713427 | COMPLETED | NA

70 participants

Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2007-07-31

Completion:

2008-05-31

Conditions

• Biliary Strictures Caused by Malignant Neoplasms

Interventions

• DEVICE

Results Available

NCT00538915 | COMPLETED | PHASE3

63 participants

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2007-09-30

Completion:

2009-07-31

Conditions

• Primary Immune Deficiency Disorders (PIDD)

Interventions

• BIOLOGICAL

Results Available

NCT00473824 | TERMINATED | PHASE2

7 participants

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2007-05-31

Completion:

2009-02-28

Conditions

• Sequelae of Viral Hepatitis
• Transplantation Infection
• Evidence of Liver Transplantation

Interventions

• BIOLOGICAL

Results Available

NCT00429273 | COMPLETED | PHASE4

212 participants

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2007-01-31

Completion:

2011-07-31

Conditions

• Attention Deficit Disorder With Hyperactivity

Interventions

• DRUG

Results Available

NCT00293462 | COMPLETED | PHASE3

91 participants

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2005-06-07

Completion:

2009-12-31

Conditions

• Head and Neck Cancer
• Mucositis Oral
• Radiation Toxicity
• Tongue Cancer

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT00179777 | COMPLETED | NA

5156 participants

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2002-05-06

Completion:

2017-03-31

Conditions

• Diabetes Mellitus, Type 1

Interventions

• DIETARY_SUPPLEMENT

Results Available

NCT00084084 | COMPLETED | PHASE2

17 participants

Replagal Enzyme Replacement Therapy for Children With Fabry Disease

Study Type:

INTERVENTIONAL

Last Updated:

2021-07-30

Start Date:

2004-06-10

Completion:

2011-06-15

Conditions

• Fabry Disease

Interventions

• DRUG

Results Available